How many units of Tesamorelin should I draw?

It depends on your vial size, BAC water, and dose. For a 2mg vial with 2mL BAC water, a beginner dose of 1000mcg is typically 100 units on a U-100 syringe. Use the calculator above for your exact numbers.

How much BAC water should I add to Tesamorelin?

The standard amount is 2mL of bacteriostatic water for a 2mg vial. More water gives a more dilute solution — easier to measure small doses. Less water means fewer injections per vial. Adjust the BAC water slider in the calculator to see how it changes your syringe units.

How long does a Tesamorelin vial last?

At a beginner dose of 1000mcg daily, a 2mg vial lasts about 2 doses. The calculator shows exact doses per vial for your selected tier.

What syringe should I use for Tesamorelin?

Most people use a U-100 insulin syringe (1mL / 100 units). For very small doses, a U-50 or U-30 syringe gives better precision. The calculator adjusts units automatically for whichever syringe you pick.

Tesamorelin Dosage Calculator

Growth HormoneInjectionFDA Approved26-38 min half-life

Tesamorelin is an FDA-approved GHRH analog marketed as Egrifta for reducing visceral adipose tissue in HIV-associated lipodystrophy.

FDA-approved with strong safety dataMost potent GHRH for GH releaseProven to reduce visceral belly fatCognitive benefits shown in studies

Vial Size

BAC Water (mL)

Dosing Level

1mg · Daily

Custom Dose (mcg) — optional

Syringe Type

100.0 units

100 units (1mL)

Concentration

1,000

mcg/mL

Draw Volume

1.000

Syringe Units

100.0

units

Doses / Vial

doses

Summary: Add 2mL BAC water to your 2mg vial. Draw to 100.0 units on a U-100 syringe for a 1mg dose. This vial will last 2 doses.

Cycle Planner

Cycle Length (weeks)

Price Per Vial ($) — optional

Subcutaneous. Typical beginner frequency: daily.

Tesamorelin Pharmacokinetics

Pharmacokinetics — Active Dose Over Time

t½ = 26-38 min

After 1 half-life (32m): 50% remainsAfter 2 half-lives (1h): 25% remainsAfter 3 half-lives (2h): 12.5% remains

At a 2mg dose: 50% = 1.0mg remaining after 32m. Recommended frequency: Daily.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.

Tesamorelin Dosing Protocol

Level	Dose / Injection	Frequency
Beginner	1mg	Daily
Moderate	2mg	Daily
Aggressive	2mg	Daily

Note: FDA-approved GHRH analog (Egrifta) for HIV lipodystrophy. Most potent GHRH for pulsatile GH release. Inject subcutaneously in abdomen. Assess IGF-1 after 4-6 weeks.

About Tesamorelin

Tesamorelin is an FDA-approved GHRH analog marketed as Egrifta for reducing visceral adipose tissue in HIV-associated lipodystrophy. It's the most potent GHRH peptide available, producing strong natural GH pulses. Beyond HIV, it's widely used for visceral belly fat reduction, cognitive enhancement, and overall GH optimization. Studies show it reduces visceral fat by ~18% without affecting subcutaneous fat or lean mass.

View full Tesamorelinguide →Add to schedule →